Search

Displaying results 4161 - 4170 of 5449 in total
  1. Drug

    Lazucirnon

    go.drugbank.com/drugs/DB15269
    Investigational

    ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).

  2. Drug

    XmAb24306

    go.drugbank.com/drugs/DB17526
    Investigational

    It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.

  3. Drug

    Ozekibart

    go.drugbank.com/drugs/DB18675
    Investigational

    It is being investigated for the treatment of chondrosarcoma.

  4. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.

  5. Drug

    Ditiocarb

    go.drugbank.com/drugs/DB02520
    Investigational

    It is the main metabolite of DISULFIRAM.

  6. Drug

    N-acetyl-beta-neuraminic acid

    go.drugbank.com/drugs/DB04265
    Experimental

    (From Dorland, 28th ed, p1518)

  7. Drug

    Tandutinib

    go.drugbank.com/drugs/DB05465
    Investigational

    MLN518 is a novel, oral, small molecule designed to inhibit type III receptor tyrosine kinases, including FLT3, (platelet-derived growth-factor receptor) PDGFR and c-KIT. Tyrosine kinases are enzymes involved in several cellular processe...

  8. Drug

    N-Acetylglucosamine

    go.drugbank.com/drugs/DB00141
    ApprovedInvestigationalNutraceutical

    The N-acetyl derivative of glucosamine.

  9. Drug

    GTI 2040

    go.drugbank.com/drugs/DB05801
    Investigational

    It belongs to the family of drugs called antisense oligonucleotides.

  10. Drug

    Dipraglurant

    go.drugbank.com/drugs/DB12733
    Investigational

    It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).